MedTrace Logo

Biological Collection on Emerging Infectious Diseases and Their Treatments

NCT07674550 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5300

Last updated 2026-06-29

No results posted yet for this study

Summary

Unprecedented changes in human-environment interactions and increasing disruptions to ecosystems and the climate have contributed to the emergence of infectious diseases (Emerging Infectious Diseases, EIDs). Advances in the treatment of cancers, malignant haematological disorders and immune-mediated inflammatory diseases are also contributing to the creation of new infectious risks among immunocompromised patient populations.

The COVID-19 pandemic has shown that structuring research prior to any outbreak is essential for the rapid implementation of responses to the emergence of an EID. The unpredictability of an EID's occurrence necessitates the planning of research projects in advance. A key element in this planning is the development of a collection of biological samples, providing a structured and immediately deployable resource for conducting pathophysiological and therapeutic research aimed at:

* Analyze the biological determinants of the microbe and the resulting infection
* Develop new tools for identification and characterization
* Study the factors (biomarkers/signatures) associated with individual patient susceptibility and response to treatment (personalized medicine)
* Understand the pathophysiology of infection to identify new targets for diagnostic, curative and preventive treatment
* Monitor the efficacy of curative and preventive treatments

Conditions

  • Emerging Infectious Diseases and Their Treatments

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Guillaume MARTIN-BLONDEL, MD, PhD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2036-06-14
Completion
2036-06-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07674550 on ClinicalTrials.gov